The New President and CEO of Dana-Farber Cancer Center – Benjamin Ebert
Benjamin Ebert, MD, PhD chair of Department of Medical Oncology at the Dana-Farber Cancer Center was recently appointed as the President and CEO of Dana-Farber Cancer Center.
Benjamin Levine Ebert is the George P. Canellos, MD, and Jean S. Canellos Professor of Medicine at Harvard Medical School.
He is a Howard Hughes Medical Institute Investigator, and an Institute Member of the Broad Institute.
He is an elected member of the following:
- The National Academy of Medicine.
- The American Society for Clinical Investigation.
- The Association of American Physicians.
“Dana-Farber is truly a remarkable organization and a global leader in innovation, and in caring and advocating for cancer patients. Together with our executive leadership team, I will continue to advance a patient-first model as we open this new chapter.” – Benjamin Ebert
He has served as the President of the American Society for Clinical Investigation.
Personal Life and Interests
Benjamin Ebert grew up in Bethesda, Maryland. His father was a psychiatrist and a scientist working at the National Institutes of Health.
This led to Dr. Ebert getting exposed to clinical medicine and research from an early age. His first job was as a math tutor for kids of all ages in high school. He was also a competitive cyclist and triathlete.
Education
Benjamin Ebert received his bachelor’s degree from Williams College and a doctorate from Oxford University as a Rhodes Scholar.
He completed an M.D. from Harvard Medical School, a residency in internal medicine at Massachusetts General Hospital, and a fellowship in hematology/oncology at the Dana-Farber Cancer Institute.
Honors and Awards
- The Till and McCollough Award from the International Society of Experimental Hematopoiesis.
- The William Dameshek Prize from the American Society of Hematology.
- The Meyenburg Prize, and mentoring and teaching awards from Harvard Medical School.
For more posts like this, visit oncodaily.com.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023